Dr Debra Peattie is Executive Director of External Innovation at Integral Health, a Boston-based pharmaceutical company using data and compute to redefine drug development. Prior to joining Integral in 2019, she was Senior Director in the Future Pipelines Discovery division of GlaxoSmithKline. A veteran life science entrepreneur, Dr Peattie concentrates on translating early-stage science into novel therapeutics. She has spent time in the Office of Technology Development at Harvard University and in Strategy & Planning at Cubist Pharmaceuticals; and has consulted independently to emerging life science companies. Earlier in her career, Dr. Peattie was a founding member of MPM Capital and a founding scientist at Vertex Pharmaceuticals.
Dr Peattie holds an MBA from Harvard Business School and a PhD in Biochemistry & Molecular Biology from Harvard University. She has served on biotechnology company boards and has published extensively in peer-reviewed journals. Dr Peattie currently holds board positions within Harvard Business School and the Faculty of Arts and Sciences at Harvard University.